All posts tagged
CAR-T Competition Heats Up with a New IND Approval
The 10 Biggest Clinical Success Stories of 2016 in European Biotech
How is European Immuno-Oncology fighting Blood Cancer?
Red Blood Cells as Cancer Drug Carriers: Market Approval gets Delayed
Universal CAR-T given to Second baby with aggressive Leukemia
Cancer: World Best Ever CAR-T Results have Just been Disclosed
Top 8 Deadliest Cancers and their Potential Cures
Cellectis has Discovered an ‘On-Switch’ to Make CAR-T Safer and Better Controlled
Cellectis Full-Steam Ahead with UCART19 Trial for Leukemia in the UK
CAR-T Phase II: 93% Complete Remission in Children with Relapsed Leukemia!
How a Breakthrough Leukemia Drug is Shaping the Future of Bispecific T-Cell Therapies
Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?
Labiotech UG, All Rights Reserved -
Send this to friend